| Schedule of condensed statements of operations by segment |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, 2026 | | | Investment | | Energy | | Automotive | | Food Packaging | | Real Estate | | Home Fashion | | Pharma | | Holding Company | | Consolidated | | | | (in millions) | Revenues: | | | | | | | | | | | | | | | | | | | | | | | | | | | | Net sales | | $ | — | | $ | 1,980 | | $ | 187 | | $ | 87 | | $ | 3 | | $ | 39 | | $ | 15 | | $ | — | | $ | 2,311 | Other revenues from operations | | | — | | | — | | | 142 | | | — | | | 18 | | | — | | | 1 | | | — | | | 161 | Net loss from investment activities | | | (300) | | | — | | | — | | | — | | | — | | | — | | | — | | | (2) | | | (302) | Interest and dividend income | | | 31 | | | 5 | | | — | | | — | | | 4 | | | — | | | — | | | 7 | | | 47 | Loss on disposition of assets, net | | | — | | | (1) | | | (1) | | | — | | | — | | | — | | | — | | | — | | | (2) | Other loss (income), net | | | — | | | (17) | | | — | | | 1 | | | 7 | | | — | | | — | | | — | | | (9) | | | | (269) | | | 1,967 | | | 328 | | | 88 | | | 32 | | | 39 | | | 16 | | | 5 | | | 2,206 | Expenses: | | | | | | | | | | | | | | | | | | | | | | | | | | | | Cost of goods sold | | | — | | | 2,095 | | | 123 | | | 78 | | | 3 | | | 32 | | | 9 | | | — | | | 2,340 | Other expenses from operations | | | — | | | — | | | 122 | | | — | | | 19 | | | — | | | — | | | — | | | 141 | Dividend expense | | | 5 | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | 5 | Selling, general and administrative | | | 4 | | | 47 | | | 109 | | | 13 | | | 5 | | | 10 | | | 14 | | | 7 | | | 209 | Interest expense | | | 1 | | | 31 | | | 1 | | | 3 | | | — | | | 1 | | | — | | | 86 | | | 123 | | | | 10 | | | 2,173 | | | 355 | | | 94 | | | 27 | | | 43 | | | 23 | | | 93 | | | 2,818 | (Loss) income before income tax benefit | | | (279) | | | (206) | | | (27) | | | (6) | | | 5 | | | (4) | | | (7) | | | (88) | | | (612) | Income tax benefit (expense) | | | — | | | 33 | | | 7 | | | (1) | | | — | | | — | | | — | | | 10 | | | 49 | Net (loss) income | | | (279) | | | (173) | | | (20) | | | (7) | | | 5 | | | (4) | | | (7) | | | (78) | | | (563) | Less: net (loss) income attributable to non-controlling interests | | | (69) | | | (34) | | | — | | | (1) | | | — | | | — | | | — | | | — | | | (104) | Net (loss) income attributable to Icahn Enterprises | | $ | (210) | | $ | (139) | | $ | (20) | | $ | (6) | | $ | 5 | | $ | (4) | | $ | (7) | | $ | (78) | | $ | (459) | Supplemental information: | | | | | | | | | | | | | | | | | | | | | | | | | | | | Capital expenditures | | $ | — | | $ | 47 | | $ | 47 | | $ | 9 | | $ | 10 | | $ | 1 | | $ | — | | $ | — | | $ | 114 | Depreciation and amortization | | $ | — | | $ | 96 | | $ | 12 | | $ | 4 | | $ | 8 | | $ | 1 | | $ | 2 | | $ | — | | $ | 123 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, 2025 | | | Investment | | Energy | | Automotive | | Food Packaging | | Real Estate | | Home Fashion | | Pharma | | Holding Company | | Consolidated | | | | (in millions) | Revenues: | | | | | | | | | | | | | | | | | | | | | | | | | | | | Net sales | | $ | — | | $ | 1,646 | | $ | 198 | | $ | 94 | | $ | — | | $ | 41 | | $ | 23 | | $ | — | | $ | 2,002 | Other revenues from operations | | | — | | | — | | | 151 | | | — | | | 17 | | | — | | | — | | | — | | | 168 | Net loss from investment activities | | | (394) | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | (394) | Interest and dividend income | | | 55 | | | 10 | | | 1 | | | — | | | — | | | — | | | — | | | 17 | | | 83 | Gain on disposition of assets, net | | | — | | | (1) | | | (2) | | | — | | | — | | | — | | | — | | | — | | | (3) | Other income, net | | | 7 | | | 2 | | | — | | | 2 | | | — | | | (1) | | | 1 | | | — | | | 11 | | | | (332) | | | 1,657 | | | 348 | | | 96 | | | 17 | | | 40 | | | 24 | | | 17 | | | 1,867 | Expenses: | | | | | | | | | | | | | | | | | | | | | | | | | | | | Cost of goods sold | | | — | | | 1,748 | | | 144 | | | 80 | | | — | | | 31 | | | 13 | | | — | | | 2,016 | Other expenses from operations | | | — | | | — | | | 135 | | | — | | | 16 | | | — | | | — | | | — | | | 151 | Dividend expense | | | 8 | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | 8 | Selling, general and administrative | | | 4 | | | 44 | | | 105 | | | 12 | | | 5 | | | 11 | | | 13 | | | 7 | | | 201 | Impairment | | | — | | | — | | | — | | | 10 | | | — | | | — | | | — | | | — | | | 10 | Restructuring, net | | | — | | | — | | | — | | | 7 | | | — | | | — | | | — | | | — | | | 7 | Interest expense | | | 6 | | | 35 | | | 1 | | | 3 | | | — | | | — | | | — | | | 83 | | | 128 | | | | 18 | | | 1,827 | | | 385 | | | 112 | | | 21 | | | 42 | | | 26 | | | 90 | | | 2,521 | (Loss) income before income tax (expense) benefit | | | (350) | | | (170) | | | (37) | | | (16) | | | (4) | | | (2) | | | (2) | | | (73) | | | (654) | Income tax (expense) benefit | | | — | | | 53 | | | 10 | | | 2 | | | — | | | — | | | — | | | 9 | | | 74 | Net (loss) income | | | (350) | | | (117) | | | (27) | | | (14) | | | (4) | | | (2) | | | (2) | | | (64) | | | (580) | Less: net (loss) income attributable to non-controlling interests | | | (126) | | | (31) | | | — | | | (1) | | | — | | | — | | | — | | | — | | | (158) | Net (loss) income attributable to Icahn Enterprises | | $ | (224) | | $ | (86) | | $ | (27) | | $ | (13) | | $ | (4) | | $ | (2) | | $ | (2) | | $ | (64) | | $ | (422) | Supplemental information: | | | | | | | | | | | | | | | | | | | | | | | | | | | | Capital expenditures | | $ | — | | $ | 51 | | $ | 24 | | $ | 7 | | $ | 4 | | $ | 2 | | $ | — | | $ | — | | $ | 88 | Depreciation and amortization | | $ | — | | $ | 84 | | $ | 17 | | $ | 5 | | $ | 4 | | $ | 1 | | $ | 7 | | $ | — | | $ | 118 |
|
| Schedule of condensed balance sheets by segment |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | March 31, 2026 | | | Investment | | Energy | | Automotive | | Food Packaging | | Real Estate | | Home Fashion | | Pharma | | Holding Company | | Consolidated | | | | (in millions) | ASSETS | | | | | | | | | | | | | | | | | | | | | | | | | | | | Cash and cash equivalents | | $ | 16 | | $ | 512 | | $ | 51 | | $ | 29 | | $ | 35 | | $ | 5 | | $ | 27 | | $ | 624 | | $ | 1,299 | Cash held at consolidated affiliated partnerships and restricted cash | | | 1,818 | | | — | | | 8 | | | — | | | — | | | 2 | | | — | | | 167 | | | 1,995 | Investments | | | 1,530 | | | 13 | | | — | | | — | | | 95 | | | — | | | — | | | — | | | 1,638 | Accounts receivable, net | | | — | | | 329 | | | 24 | | | 63 | | | 11 | | | 27 | | | 27 | | | — | | | 481 | Related party note receivable | | | — | | | — | | | — | | | — | | | 132 | | | — | | | — | | | — | | | 132 | Inventories, net | | | — | | | 553 | | | 163 | | | 99 | | | — | | | 90 | | | 22 | | | — | | | 927 | Property, plant and equipment, net | | | — | | | 2,309 | | | 363 | | | 143 | | | 761 | | | 55 | | | — | | | 3 | | | 3,634 | Goodwill and intangible assets, net | | | — | | | 134 | | | 314 | | | 21 | | | — | | | 21 | | | 140 | | | — | | | 630 | Other assets | | | 948 | | | 418 | | | 375 | | | 78 | | | 110 | | | 15 | | | 6 | | | 247 | | | 2,197 | Total assets | | $ | 4,312 | | $ | 4,268 | | $ | 1,298 | | $ | 433 | | $ | 1,144 | | $ | 215 | | $ | 222 | | $ | 1,041 | | $ | 12,933 | LIABILITIES AND EQUITY | | | | | | | | | | | | | | | | | | | | | | | | | | | | Accounts payable, accrued expenses and other liabilities | | $ | 675 | | $ | 1,374 | | $ | 721 | | $ | 107 | | $ | 29 | | $ | 39 | | $ | 61 | | $ | 440 | | $ | 3,446 | Securities sold, not yet purchased, at fair value | | | 748 | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | 748 | Debt | | | — | | | 1,784 | | | 26 | | | 131 | | | 1 | | | 25 | | | — | | | 4,425 | | | 6,392 | Total liabilities | | | 1,423 | | | 3,158 | | | 747 | | | 238 | | | 30 | | | 64 | | | 61 | | | 4,865 | | | 10,586 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Equity attributable to Icahn Enterprises | | | 2,221 | | | 589 | | | 551 | | | 184 | | | 1,114 | | | 151 | | | 161 | | | (3,824) | | | 1,147 | Equity attributable to non-controlling interests | | | 668 | | | 521 | | | — | | | 11 | | | — | | | — | | | — | | | — | | | 1,200 | Total equity | | | 2,889 | | | 1,110 | | | 551 | | | 195 | | | 1,114 | | | 151 | | | 161 | | | (3,824) | | | 2,347 | Total liabilities and equity | | $ | 4,312 | | $ | 4,268 | | $ | 1,298 | | $ | 433 | | $ | 1,144 | | $ | 215 | | $ | 222 | | $ | 1,041 | | $ | 12,933 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | December 31, 2025 | | | Investment | | Energy | | Automotive | | Food Packaging | | Real Estate | | Home Fashion | | Pharma | | Holding Company | | Consolidated | | | | (in millions) | ASSETS | | | | | | | | | | | | | | | | | | | | | | | | | | | | Cash and cash equivalents | | $ | 16 | | $ | 511 | | $ | 14 | | $ | 9 | | $ | 31 | | $ | 4 | | $ | 26 | | $ | 839 | | $ | 1,450 | Cash held at consolidated affiliated partnerships and restricted cash | | | 1,788 | | | — | | | 8 | | | — | | | — | | | 3 | | | — | | | 170 | | | 1,969 | Investments | | | 2,146 | | | 17 | | | — | | | — | | | 88 | | | — | | | — | | | — | | | 2,251 | Accounts receivable, net | | | — | | | 235 | | | 25 | | | 60 | | | 10 | | | 27 | | | 36 | | | — | | | 393 | Related party notes receivable, net | | | — | | | — | | | — | | | — | | | 129 | | | — | | | — | | | — | | | 129 | Inventories, net | | | — | | | 472 | | | 165 | | | 97 | | | — | | | 87 | | | 24 | | | — | | | 845 | Property, plant and equipment, net | | | — | | | 2,333 | | | 351 | | | 141 | | | 787 | | | 55 | | | — | | | 3 | | | 3,670 | Goodwill and intangible assets, net | | | — | | | 139 | | | 316 | | | 21 | | | — | | | 21 | | | 142 | | | — | | | 639 | Other assets | | | 1,661 | | | 422 | | | 369 | | | 79 | | | 79 | | | 15 | | | 8 | | | 236 | | | 2,869 | Total assets | | $ | 5,611 | | $ | 4,129 | | $ | 1,248 | | $ | 407 | | $ | 1,124 | | $ | 212 | | $ | 236 | | $ | 1,248 | | $ | 14,215 | LIABILITIES AND EQUITY | | | | | | | | | | | | | | | | | | | | | | | | | | | | Accounts payable, accrued expenses and other liabilities | | $ | 606 | | $ | 1,079 | | $ | 772 | | $ | 117 | | $ | 32 | | $ | 34 | | $ | 67 | | $ | 84 | | $ | 2,791 | Securities sold, not yet purchased, at fair value | | | 1,382 | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | 1,382 | Debt | | | — | | | 1,765 | | | 21 | | | 142 | | | 1 | | | 23 | | | — | | | 4,664 | | | 6,616 | Total liabilities | | | 1,988 | | | 2,844 | | | 793 | | | 259 | | | 33 | | | 57 | | | 67 | | | 4,748 | | | 10,789 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Equity attributable to Icahn Enterprises | | | 2,711 | | | 722 | | | 455 | | | 139 | | | 1,091 | | | 155 | | | 169 | | | (3,500) | | | 1,942 | Equity attributable to non-controlling interests | | | 912 | | | 563 | | | — | | | 9 | | | — | | | — | | | — | | | — | | | 1,484 | Total equity | | | 3,623 | | | 1,285 | | | 455 | | | 148 | | | 1,091 | | | 155 | | | 169 | | | (3,500) | | | 3,426 | Total liabilities and equity | | $ | 5,611 | | $ | 4,129 | | $ | 1,248 | | $ | 407 | | $ | 1,124 | | $ | 212 | | $ | 236 | | $ | 1,248 | | $ | 14,215 |
|